References
- Boushey H A, Holtzman M J, Sheller J R, Nadel JA. Bronchial hyperreactivity. Am Rev Respir Dis 1980; 121: 389
- Hargreave F E, Ryan G, Thomson N C, O'Byrne P M, Latimer K, Juniper E F, et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981; 68: 347
- Larsen GL. Asthma in children. N Engl J Med 1992; 326: 1540
- Hargreave F E, O'Byrne P M, Ramsdale EH. Mediators, airway responsiveness, and asthma. J Allergy Clin Immunol 1985; 76: 272
- Bel E H, Timmers M C, Hermans J, Dijkman J H, Sterk PJ. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am Rev Respir Dis 1990; 141: 21
- Katsunuma T, Hashimoto K, Akimoto K, Ebisawa M, likura Y. Effect of inhaled beclomethasone dipropionate on bronchial responsiveness in patients with asthma. Ann Allergy 1993; 70: 165
- A six-part asthma management program. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. NHLB1/WHO workshop report. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD 1995; 69–117, NIH Publication No. 95–3659
- Caddie J, Petrie G R, Reid I W, Skinner C, Sinclair D J, Palmer KN. Aerosol beclomethasone dipropionate: A dose-response study in chronic bronchial asthma. Lancet 1973; 2: 280
- Geddes DM. Inhaled corticosteroids: Benefits and risks. Thorax 1992; 47: 404
- Chervinsky P, Van As A, Bronsky E A, Dockhorn R, Noonan M, LaForce C, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 1994; 94: 676
- Wassermann S I, Gross G N, Schoenwetter W F, Munk Z M, Kral K M, Schaberg A, Kellerman DJ. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. J Asthma 1996; 33: 265
- Wolfe J D, Seiner J C, Mendelson L M, Hampel F, Schaberg A. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study. Clin Ther 1996; 18: 635
- Kraan J, Koëter G H, van der, Mark T W, Boorsma M, Kukler J, Sluiter H J, et al. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis 1988; 137: 44
- American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225
- Polgar G, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. WB Saunders, Philadelphia 1971
- Crapo R O, Morris A H, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659
- De Vries K, Goei J T, Booy-Noord H, Orie N GM. Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and chronic bronchitis patients. Int Arch Allergy 1962; 20: 93
- Altouhyan R EL. Variation of drug action on airway obstruction in man. Thorax 1964; 19: 406
- van Elteren PH. On the combination of independent two-sample tests of Wilcoxon. Bull Int Statist Inst 1960; 37: 351
- Juniper E F, Kline P A, Vanzleleghem M A, Ramsdale H E, O'Byrne P M, Hargreave FE. Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics. Eur Respir J 1990; 3: 1122
- Noonan M, Chervinsky P, Busse W W, Weisberg S C, Pinnas J, deBoisblanc B P, et al. Fluticasone propionate aerosol reduces oral prednisone requirements while it improves control of asthma and quality of life. Am Rev Respir Crit Care 1995; 152: 1467
- Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: A dose-response study. J Allergy Clin Immunol 1996; 95: 29
- LaForce C, Goldstein M, Storms W, Levy B, Li J, Littlejohn T, et al. Comparison of inhaled fluticasone propionate and flunisolide effects on the HPA axis as assessed by 6-hour osyntropin infusion testing. Eur Respir J 1996; 9: 163s, (Suppl 23), (abstract)
- Sorkness C A, Howland W C, Strieker W E, Tita J A, Noveck R J, Dockhorn RJ. Comparison of inhaled fluticasone propionate and triamcinolone acetonide effects on the HPA axis as assessed by 6-hour cosyntropin infusion testing. Eur Respir J 1996; 9: 163s, (Suppl 23), (abstract)
- Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84: 25, (Suppl A)